- Supported exchanges /
- TW /
- 1783.TW
Maxigen Biotech Inc (1783 TW) stock market data APIs
Maxigen Biotech Inc. researches, develops, produces, and sells implantable medical device and cosmetic products in Taiwan, America, Europe, rest of Asia, and internationally. It operates in two segments, Biomedical Products and Consumer Products. The company offers intra-articular injections under the ArtiAid, ArtiAid Plus, and ArtiBest names to treat osteoarthritis; Foramic, a bone substitute granule; FormaGraft, a bone graft substitute; GingivAid, a collagen dental grafts for use in dental implant surgery; and BestAid, a collagen bone graft. It also provides FormaAid, a guided tissue regeneration membrane; HealiAid, a collagen wound dressing product for dental and surgical use; PreviscAid, an ophthalmic viscoelastic device; BiVisc, an ophthalmic viscoelastic system; ViscAid, an ophthalmic viscoelastic device; and dermal filler injections under the Formaderm brand. In addition, the company engages in the manufacturing and sales of beauty care products. Maxigen Biotech Inc. was incorporated in 1998 and is headquartered in Taoyuan City, Taiwan.
Maxigen Biotech Inc Financial Data Overview
| 44 | |
| 43.7 | |
| - | |
| 44.25 | |
| 43.6 | |
| 37.25-51.5 | |
| 3 892 M | |
| 25.2601 | |
| 89 070 K | |
| 609 M | |
| 0.5222 | |
| 0.885 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Maxigen Biotech Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 609 M
- EBITDA 152 M
- Earnings Per Share 1.73
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Maxigen Biotech Inc Earnings via APIs
- Latest Release 2023-05-03
- EPS/Forecast NaN
Get Maxigen Biotech Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
